AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

KALA BIO, Inc. Director's Dealing 2025

Dec 3, 2025

35091_dirs_2025-12-03_e751f17b-887e-40c9-923d-a4f14ff637b0.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: KALA BIO, Inc. (KALA)
CIK: 0001479419
Period of Report: 2025-11-25

Reporting Person: OXFORD FINANCE LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1620000	Direct